Alpha 2.0
Login Register
» Articles » PMID: 19103739

Regression of Parathyroid Hyperplasia by Calcimimetics--fact or Illusion?

Overview
Journal Nephrol Dial Transplant
Publisher Oxford University Press
Specialties General Surgery
Nephrology
Date 2008 Dec 24
PMID 19103739
Citations 5
Authors
Hirotaka Komaba
Masafumi Fukagawa
Affiliations
Soon will be listed here.
Citing Articles

EARLIER: an observational study to evaluate the use of cinacalcet in incident hemodialysis patients with secondary hyperparathyroidism in daily clinical practice.

Hemetsberger M, Oberbauer R, Erb H, Pronai W Wien Med Wochenschr. 2015; 165(19-20):410-8.

PMID: 26302869 DOI: 10.1007/s10354-015-0379-0.

Cinacalcet HCl prevents development of parathyroid gland hyperplasia and reverses established parathyroid gland hyperplasia in a rodent model of CKD.

Miller G, Davis J, Shatzen E, Colloton M, Martin D, Henley C Nephrol Dial Transplant. 2011; 27(6):2198-205.

PMID: 22036941 PMC: 3363978. DOI: 10.1093/ndt/gfr589.

Effective use of cinacalcet for the treatment of secondary hyperparathyroidism in Austrian dialysis patients--results of the Austrian cohort of the ECHO study.

Zitt E, Jager C, Rosenkranz A, Eigner M, Kodras K, Kovarik J Wien Klin Wochenschr. 2011; 123(1-2):45-52.

PMID: 21253777 DOI: 10.1007/s00508-010-1515-x.

Cinacalcet effectively reduces parathyroid hormone secretion and gland volume regardless of pretreatment gland size in patients with secondary hyperparathyroidism.

Komaba H, Nakanishi S, Fujimori A, Tanaka M, Shin J, Shibuya K Clin J Am Soc Nephrol. 2010; 5(12):2305-14.

PMID: 20798251 PMC: 2994093. DOI: 10.2215/CJN.02110310.

Failed Switching off in the MIBI-Parathyroid Scintigraphy in a Dialyzed Patient with Secondary Hyperparathyroidism Responsive to Cinacalcet Therapy.

Bolasco P, Serra A, Loi M, Galfre A, Piga M Int J Endocrinol. 2010; 2010:206801.

PMID: 20652073 PMC: 2905699. DOI: 10.1155/2010/206801.